About this episode

This episode discusses advancements in molecular technologies for early cancer detection and treatment monitoring.

This episode explores the latest advancements in personalized DNA and RNA technologies for early cancer detection, diagnostics, and treatment monitoring. New technologies identify molecular signatures of tumors that help predict onset and re-occurrence of disease. Dr. Nathan Montgomery from Neo Genomics Laboratories discusses how molecular residual disease testing, liquid biopsies, and genomic sequencing are transforming oncology care.

More episodes of Talking Biotech with Dr. Kevin Folta

• New Technology in Severe Burn Care - Dr. Katie Bush · June 1, 2026 · 29 min
• Strategies in Combating Chronic Kidney Disease - Dr. Salvatore Viscomi · May 16, 2026 · 38 min

Explore listener stats, chart rankings, contacts and more on the Talking Biotech with Dr. Kevin Folta podcast page.